pharmaphorum November 27, 2023
EVERSANA’s alliance with Amazon Web Services (AWS) on the application of generative artificial intelligence (genAI) to the pharma sector has borne its first fruit – a new tool to tackle the time-consuming and error-prone task of getting medical and regulatory content approvals.
The two organisations first joined forces in the summer with the ambition to ‘pharmatise’ the use of genAI, and the new medical and regulatory review solution is billed as the first of several genAI-based applications that they say will “drive greater efficiency and business value for companies and ultimately improved patient outcomes.”
Commercial services company EVERSANA – which recently acquired pharmaphorum – said the traditional way that brands and marketing teams ensure the accuracy and compliance of claims...
Today's Sponsors
Today's Sponsor